PREMARIN TABLETS 0.625MG

PREMARIN TABLETS 0.625MG

PREMARIN TABLETS 0.625MG, also known in Japanese as プレマリン錠 0.625mg, is an oral estrogen hormone replacement therapy medicine containing conjugated estrogens. It is commonly used under medical supervision for the management of estrogen-deficiency related conditions, menopausal symptoms, and certain gynecological conditions.

Each tablet contains 0.625mg of conjugated estrogens. Premarin is a prescription hormone product and should only be used according to a healthcare professional’s instructions.

Product Information

• Product Name: PREMARIN TABLETS 0.625MG
• Japanese Name: プレマリン錠 0.625mg
• Chinese Name: 普力馬林錠 0.625mg
• Common Chinese SEO Name: 更年期雌激素北馬素普力馬林
• Active Ingredient: Conjugated Estrogens
• Japanese Ingredient: 結合型エストロゲン
• Strength: 0.625mg per tablet
• Package Size: 140 tablets
• Japanese Package Size: 140錠（14錠 × 10）
• Dosage Form: Oral tablet
• Route of Administration: Oral use
• Brand: Premarin
• Manufacturer: Pfizer
• Use Level: Prescription medicine / professional medical supervision required

What Is Premarin 0.625mg?

Premarin Tablets 0.625mg contain conjugated estrogens, a mixture of estrogenic substances that help replace or supplement estrogen levels in the body. Estrogen plays an important role in reproductive tissue health, bone metabolism, and the regulation of menopausal symptoms.

During menopause or ovarian insufficiency, estrogen levels decline, which may lead to symptoms such as hot flashes, sweating, sleep disturbance, vaginal dryness, irritation, and urogenital discomfort. Premarin may be prescribed by a healthcare provider to help relieve these symptoms when estrogen therapy is considered appropriate.

Indications and Uses

Premarin Tablets 0.625mg may be used under medical supervision for conditions such as:

• Menopausal symptoms caused by estrogen deficiency
• Vasomotor symptoms such as hot flashes and night sweats
• Vaginal dryness, irritation, or urogenital atrophy related to menopause
• Ovarian insufficiency
• Ovarian dysfunction
• Functional uterine bleeding, when determined appropriate by a physician
• Vaginitis associated with estrogen deficiency
• Prevention of osteoporosis in selected postmenopausal women at elevated risk, when non-estrogen therapies are not suitable

Actual indications may vary by country, prescribing information, and the judgment of the healthcare provider.

Dosage and Administration

Premarin should be taken only as prescribed by a healthcare professional. Dosage depends on the patient’s condition, treatment goals, medical history, and individual response.

• For conjugated estrogens, a usual adult oral dose may range from 0.625mg to 1.25mg per day, depending on the indication.
• For dysfunctional uterine bleeding or vaginitis, dosage may differ and should be directed by a healthcare provider.
• The tablet is taken orally and may be taken with or without food.
• Use the lowest effective dose for the shortest duration consistent with treatment goals and risks.
• Do not change the dose or stop treatment without consulting a healthcare provider.

Important Clinical Notes

• If treatment is needed only for vaginal or vulvar atrophic symptoms, topical vaginal preparations may be considered by the healthcare provider.
• For osteoporosis prevention, estrogen therapy is generally considered only for postmenopausal women at significant risk when other non-estrogen options are not appropriate.
• Women with a uterus may require progestin therapy in addition to estrogen to reduce the risk of endometrial hyperplasia, depending on medical assessment.
• Regular medical review is important during hormone replacement therapy.

Contraindications

Premarin should not be used in patients with certain medical conditions unless specifically directed by a healthcare professional. Contraindications may include:

• Known or suspected breast cancer
• Known or suspected estrogen-dependent cancer
• Undiagnosed abnormal genital bleeding
• Active or previous blood clot disorders, unless a physician determines otherwise
• Active or recent stroke or heart attack
• Active liver disease or significant liver dysfunction
• Known hypersensitivity to conjugated estrogens or any component of the product
• Pregnancy or suspected pregnancy

Warnings and Precautions

• Use only under medical supervision.
• Estrogen therapy may increase the risk of blood clots, stroke, heart attack, breast cancer, and endometrial cancer in certain patients.
• Report any abnormal vaginal bleeding immediately.
• Seek urgent medical attention for chest pain, sudden shortness of breath, severe headache, vision changes, weakness on one side of the body, leg swelling, or sudden severe pain.
• Patients with high blood pressure, diabetes, migraine, gallbladder disease, liver problems, history of cancer, or clotting risk should inform their healthcare provider before use.
• Regular check-ups, including breast and gynecological assessments, may be required.
• Do not use during pregnancy.
• Consult a healthcare provider before use while breastfeeding.

Possible Side Effects

Possible side effects may include:

• Breast tenderness or enlargement
• Nausea
• Headache
• Bloating
• Abdominal discomfort
• Fluid retention
• Mood changes
• Vaginal spotting or bleeding
• Weight change
• Changes in libido

Serious but less common risks may include:

• Blood clots
• Stroke
• Heart attack
• Breast cancer risk increase with certain regimens
• Endometrial hyperplasia or endometrial cancer risk when estrogen is used without appropriate progestin in women with a uterus
• Gallbladder disease
• Severe allergic reaction

Drug Interactions

Inform your healthcare provider about all medicines, supplements, and herbal products you are using. Some products may affect estrogen levels or treatment safety, including certain anticonvulsants, antibiotics, antifungals, antiviral medicines, thyroid medicines, anticoagulants, and herbal products such as St. John’s wort.

Storage

• Store according to the instructions on the official product packaging or prescribing information.
• Keep at room temperature unless otherwise directed.
• Protect from moisture, heat, and direct sunlight.
• Keep out of reach of children.
• Do not use after the expiry date printed on the packaging.

Package Contents

• Premarin Tablets 0.625mg
• 140 tablets per box
• Japanese package format: 14 tablets × 10 sheets

Important Disclaimer

This product information is provided for general reference and SEO description purposes only. It does not replace professional medical advice, diagnosis, treatment, official prescribing information, or product labeling. PREMARIN TABLETS 0.625MG should be used only under the supervision of a qualified healthcare professional and according to applicable local regulations.